LivingGLP1
Study S000702

Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)

Registration

Registration
NCT01817569
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
2948
Start
2011-02-13
Primary completion
2019-10-03
Lead sponsor
AstraZeneca
Conditions
Type 2 Diabetes
Results posted
FALSE
Secondary identifiers
REGISTRY:EUPAS19606

Registered primary outcomes

  • Adverse event incidence. [3 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.